CDDO-3P-Imidazolide is primarily used in research and development for its potential therapeutic applications. It is known for its role in modulating inflammatory pathways and oxidative stress, making it a candidate for studying diseases such as cancer, neurodegenerative disorders, and autoimmune conditions. Its ability to activate the Nrf2 pathway, which regulates antioxidant proteins, is of particular interest in developing treatments for conditions involving chronic inflammation or oxidative damage. Additionally, it is explored for its anti-proliferative properties in cancer research, where it may inhibit tumor growth or induce apoptosis in cancer cells. Researchers also investigate its potential in protecting against organ damage caused by ischemia-reperfusion injury, making it relevant in fields like cardiology and neurology. Its applications remain largely experimental, with ongoing studies aimed at understanding its mechanisms and therapeutic potential.